Skip to content

13F-HR filed by CVI Holdings, LLC

CVI Holdings, LLC filed this 13F-HR for the quarter ended 2018-03-31, filed 2018-05-15, with 47 holding rows worth $73,658,000.

Accession
0001728194-18-000009
Filed
2018-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2018

A holdings report, 47 entries on the cover page, a total value of $73,658,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $73,658,000 with VALUE read as thousands by filing date, 13F file number 028-18767. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TIMKENSTEEL CORP887399AA1CONVERTIBLE BOND11,455,000$16,790,000thousands by filing dateprincipal
ANI PHARMACEUTICALS INC00182CAA1NOTE 3.00012/09,000,000$9,813,000thousands by filing dateprincipal
EROS INTL PLCG3788M114SHS NEW817,017$8,905,000thousands by filing date
AGREE RLTY CORP COM008492100REIT111,649$5,364,000thousands by filing date
HELIOS & MATHESON ANALYTICS42327L200COM NEW1,187,534$3,361,000thousands by filing date
SYNERGY PHARMACEUTICALS DEL871639308COM NEW1,767,858$3,235,000thousands by filing date
AKEBIA THERAPEUTICS INC00972D105COMMON STOCK327,457$3,121,000thousands by filing date
MACROGENICS INC556099109COM97,505$2,453,000thousands by filing date
INVITAE CORP46185L103COM453,358$2,126,000thousands by filing date
ZOSANO PHARMA CORP98979H202COM NEW374,612$1,888,000thousands by filing date
SCYNEXIS INC COM NEW811292101Common Stock1,302,830$1,746,000thousands by filing date
AVID BIOSERVICES INC05368M106COM591,991$1,729,000thousands by filing date
Egalet Corporation28226BAB0Note 5.50% 4/1/204,500,000$1,662,000thousands by filing dateprincipal
SENSEONICS HLDGS INC81727UAA3NOTE 5.250% 2/01,500,000$1,611,000thousands by filing dateprincipal
AURYN RES INC05208W108COM1,124,759$1,480,000thousands by filing date
NOVAN INC66988N106COM459,798$1,347,000thousands by filing date
GLADSTONE LAND CORP376549101REIT74,336$898,000thousands by filing date
RECON TECHNOLOGY LTDG7415M108SHS729,710$861,000thousands by filing date
APPLIED DNA SCIENCES INC03815U201COM NEW578,141$833,000thousands by filing date
AFFIMED N VN01045108COM360,455$667,000thousands by filing date
MIRAGEN THERAPEUTICS INC60463E103COM92,200$646,000thousands by filing date
DARE BIOSCIENCE INC23666P101COMMON471,661$395,000thousands by filing date
SIERRA ONCOLOGY INC82640U107COM189,516$392,000thousands by filing date
Ampio Pharmaceuticals03209T109COM102,300$348,000thousands by filing dateput
INVUITY INC46187J205COM NEW78,411$302,000thousands by filing date
RESONANT INC76118L102COM83,746$267,000thousands by filing date
SENESTECH INC81720R109COM513,682$262,000thousands by filing date
ESSA PHARMA INC29668H104COM1,146,761$219,000thousands by filing date
PLX PHARMA INC. XXXBANKRUPTCY EFF: 10/02/2372942A107COMMON STOCK46,096$154,000thousands by filing date
SEANERGY MARITIME HLDGS CORPY73760145*W EXP 11/10/2021,180,400$143,000thousands by filing date
RXI PHARMACEUTICALS CORP NEW74979C121*W EXP 12/16/202221,686$100,000thousands by filing date
CELLECTAR BIOSCIENCES INC15117F138*W EXP 04/20/202207,500$87,000thousands by filing date
BIONDVAX PHARMACEUTICALS LTD09073Q113*W EXP 05/15/20272,800$87,000thousands by filing date
IMMURON LTDQ4867H223*W EXP 06/08/20222,041$86,000thousands by filing date
SIGMA LABS INC826598112*W EXP 02/15/202215,300$81,000thousands by filing date
AMERI HLDGS INC WT EXP 11082302362F112Stock125,503$56,000thousands by filing date
ONCONOVA THERAPEUTICS INC68232V116*W EXP 07/11/202173,112$52,000thousands by filing date
SOLIGENIX INC834223117*W EXP 11/14/20261,000$35,000thousands by filing date
CELLECT BIOTECHNOLOGY LTD15116C110*W EXP 08/03/20212,570$24,000thousands by filing date
BENITEC BIOPHARMA LTD082053117*W EXP 08/14/20250,000$12,000thousands by filing date
APPLIED DNA SCIENCES INC03815U110*W EXP 11/21/20131,407$8,000thousands by filing date
ADVAXIS INC007624117*W EXP 10/22/20115,150$6,000thousands by filing date
MYND ANALYTICS INC62857N111*W EXP 06/29/20213,700$4,000thousands by filing date
INSPIREMD INC45779A135*W EXP 03/14/20248,000$1,000thousands by filing date
EYEGATE PHARMACEUTICALS INC30233M115*W EXP 08/05/20212,900$1,000thousands by filing date
ENERGY FUELS INC292671179*W EXP 09/277,777$0thousands by filing dateValue filed as zero, left out of ratios.
CEL SCI CORP150837177*W EXP 10/11/201750,000$0thousands by filing dateValue filed as zero, left out of ratios.

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001728194-18-000009this filing2018-05-15acceptance time not in the bulk data set